Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Dosing of Paricalcitol Based on iPTH Parathyroid Hormone Levels in Hemodialysis Patients With Secondary Hyperparathyroidism

NCT00307840 is registered in ClinicalTrials.gov with Papageorgiou General Hospital as lead sponsor.

NCT NCT00307840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00307840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Dosing of Paricalcitol Based on iPTH Parathyroid Hormone Levels in Hemodialysis Patients With Secondary Hyperparathyroidism
Lead sponsor
Papageorgiou General Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
July 31, 2005
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism